HS
ABVX

HighVista Strategies’s Abivax ABVX Stock Holding History

HighVista Strategies’s Portfolio ABVX Stock Details ABVX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$15.1M Sell
113,031
-223
-0.2% -$25.2K 3.43% 2
2026
Q1 		$12.6M Buy
113,254
+41,069
+57% +$4.86M 3.48% 2
2025
Q4 		$9.73M Sell
72,185
-112,283
-61% -$12.3M 2.51% 5
2025
Q3 		$15.7M Buy
184,468
+133,312
+261% +$8.17M 3.84% 2
2025
Q2 		$391K Buy
51,156
+2,092
+4% +$13.6K 0.14% 135
2025
Q1 		$307K Hold
49,064
– – 0.12% 138
2024
Q4 		$359K Hold
49,064
– – 0.13% 132
2024
Q3 		$565K Sell
49,064
-445
-0.9% -$5.33K 0.19% 120
2024
Q2 		$655K Sell
49,509
-8,253
-14% -$118K 0.24% 110
2024
Q1 		$826K Buy
+57,762
New +$745K 0.29% 101

Other funds holding ABVX

TCM
TCG Crossover Management Palo Alto, California $4.16B AUM 983.43% 1-Year Est. Return
HI
Helikon Investments London, United Kingdom $3.35B AUM 55.08% 1-Year Est. Return
DGM
Darwin Global Management St. Helier, Jersey $3.76B AUM 342.13% 1-Year Est. Return
VPC
Vestal Point Capital New York $4.28B AUM 239% 1-Year Est. Return
JT
Jupiter Topco New York $245B AUM
UBS Group
UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return
ACM
ADAR1 Capital Management Austin, Texas $2.19B AUM 374.99% 1-Year Est. Return
CP
Caligan Partners New York $2.13B AUM 758.65% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $875B AUM 40.89% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

HighVista Strategies's ABVX Position: Q2 2026 in Review

HighVista Strategies reduced its Abivax (ABVX) stake by 0.2% in Q2 2026, selling an estimated $25.2K and leaving 113,031 shares worth $15.1M. The position accounts for 3.43% of the portfolio, ranked #2.

HighVista Strategies first reported a position in ABVX in Q1 2024 and has held it in 10 quarters since. The position peaked at $15.7M in Q3 2025. 302 funds tracked by Wall St. Rank hold ABVX as of Q2 2026.

  • HighVista Strategies held 113,031 shares of Abivax worth $15.1M as of Q2 2026.
  • HighVista Strategies sold 223 Abivax shares in Q2 2026, an estimated $25.2K.
  • Abivax made up 3.43% of HighVista Strategies's portfolio in Q2 2026, its #2 holding.
  • HighVista Strategies first reported a position in Abivax in Q1 2024 and has held it in 10 quarters since.
  • HighVista Strategies's Abivax position peaked at $15.7M in Q3 2025.
  • 302 funds tracked by Wall St. Rank held Abivax as of Q2 2026.

Based on HighVista Strategies's 13F filing for Q2 2026, filed 14 Aug 2026.